Skip to Content

E LENV 4 mg (Lenvima 4 mg)

Generic Name: lenvatinib

Pill with imprint E LENV 4 mg is Red, Capsule-shape and has been identified as Lenvima 4 mg. It is supplied by Eisai Co., Ltd..

Lenvima is used in the treatment of hepatocellular carcinoma; endometrial cancer; thyroid cancer; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Lenvima 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E LENV 4 mg

Lenvima 4 mg E LENV 4 mg

Lenvima

Generic Name
lenvatinib
Imprint
E LENV 4 mg
Strength
4 mg
Color
Red
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Eisai Co., Ltd.
National Drug Code (NDC)
62856-0712

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.